ZymoGenetics boosts sales team to market Recothrom

03/3/2008 | SeattlePI.com

Seattle-based ZymoGenetics has established a sales team following the FDA's approval of Recothrom -- a biotech form of the human blood-clotting protein thrombin aimed at preventing blood loss during surgery -- to promote the drug to surgeons. One analyst said the drug could attain annual sales of $300 million within three to five years.

View Full Article in:

SeattlePI.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI